Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis

Introduction Progressive multifocal leukoencephalopathy (PML) was first described among patients affected by hematological or solid tumors. Following the human immunodeficiency virus (HIV) epidemic, people living with HIV have represented most cases for more than a decade. With the diffusion of high...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug safety 2024-04, Vol.47 (4), p.333-354
Hauptverfasser:	Rindi, Lorenzo Vittorio, Zaçe, Drieda, Braccialarghe, Neva, Massa, Barbara, Barchi, Virginia, Iannazzo, Roberta, Fato, Ilenia, De Maria, Francesco, Kontogiannis, Dimitra, Malagnino, Vincenzo, Sarmati, Loredana, Iannetta, Marco
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Antigens Antiretroviral agents Azathioprine Canada Confidence intervals Copolymer 1 Dosage Drug development Drug dosages Drug Safety and Pharmacovigilance Drug therapy Drugs Female Hematology Heterogeneity Highly active antiretroviral therapy HIV HIV Infections - drug therapy Human immunodeficiency virus Humans Immune system Immunologic Factors - adverse effects Immunomodulation Immunomodulators Immunosuppressive agents Infliximab Leukoencephalopathy Leukoencephalopathy, Progressive Multifocal - chemically induced Leukoencephalopathy, Progressive Multifocal - epidemiology Male Malignancy Median (statistics) Medicine Medicine & Public Health Meta-analysis Monoclonal antibodies Multiple sclerosis Multiple Sclerosis - drug therapy Natalizumab - adverse effects Neoplasms Pathology Patients Pharmacology/Toxicology Primary immunodeficiencies Progressive multifocal leukoencephalopathy Proteins Risk Rituximab Sexually transmitted diseases Solid tumors Statistical analysis STD Systematic Review Tacrolimus Therapy Time measurement Tumor necrosis factor-α Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!